Literature DB >> 17226006

[Liposuction curettage versus Botox for axillary hyperhidrosis. A prospective study of the quality of life].

C Ottomann1, J Blazek, B Hartmann, T Muehlberger.   

Abstract

BACKGROUND: Axillary hyperhidrosis is a dysfunction of the secretion of sweat glands. Conservative treatment modalities are mostly ineffective. Liposuction combined with subcutaneous curettage (TLC) destroys the sweat glands, while Botox injections inhibit the cholinergic transmission. MATERIAL AND
METHOD: Of a total of 88 patients, TLC was carried out in 47 and 41 patients received intradermal Botox injections. The effect of both forms of treatment on the quality of life was assessed using a specific hyperhidrosis questionnaire and was correlated with sweat volumes measured by gravimetry.
RESULTS: Follow-up after 6 months showed significantly changed sweat volumes of 52+/-41 mg/min of TLC patients versus 78+/-87 mg/min in the Botox group. In the TLC group 91% and in the Botox group 98% were satisfied with the result.
CONCLUSION: The stress of a single surgical intervention is to be weighed against the necessary repetitive application of multiple Botox injections. Both methods are superior to other, more radical surgical methods in terms of efficacy and complication rates. Botox and TLC lead to a significant improvement of the quality of life.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17226006     DOI: 10.1007/s00104-006-1288-y

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  17 in total

Review 1.  Pathophysiology of sweating.

Authors:  Erhard Hölzle
Journal:  Curr Probl Dermatol       Date:  2002

Review 2.  Disorders of sweat glands: hyperhidrosis: unapproved treatments.

Authors:  Jessie S Cheung; Barry A Solomon
Journal:  Clin Dermatol       Date:  2002 Nov-Dec       Impact factor: 3.541

3.  Palmar hyperhidrosis and its surgical treatment: a report of 100 cases.

Authors:  R Adar; A Kurchin; A Zweig; M Mozes
Journal:  Ann Surg       Date:  1977-07       Impact factor: 12.969

4.  Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis.

Authors:  J Pinnagoda; R A Tupker; T Agner; J Serup
Journal:  Contact Dermatitis       Date:  1990-03       Impact factor: 6.600

Review 5.  Comparative physiology of sweating.

Authors:  D M Jenkinson
Journal:  Br J Dermatol       Date:  1973-04       Impact factor: 9.302

6.  Subcutaneous curettage vs. injection of botulinum toxin A for treatment of axillary hyperhidrosis.

Authors:  R Rompel; S Scholz
Journal:  J Eur Acad Dermatol Venereol       Date:  2001-05       Impact factor: 6.166

7.  Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial.

Authors:  M K Naumann; H Hamm; N J Lowe
Journal:  Br J Dermatol       Date:  2002-12       Impact factor: 9.302

8.  A comparative study of the surgical treatment of axillary osmidrosis by instrument, manual, and combined subcutaneous shaving procedures.

Authors:  D H Park; T M Kim; D G Han; K Y Ahn
Journal:  Ann Plast Surg       Date:  1998-11       Impact factor: 1.539

Review 9.  Management of primary hyperhidrosis: a summary of the different treatment modalities.

Authors:  Maureen Connolly; David de Berker
Journal:  Am J Clin Dermatol       Date:  2003       Impact factor: 7.403

Review 10.  Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis.

Authors:  Oliver P Kreyden; E Paul Scheidegger
Journal:  Clin Dermatol       Date:  2004 Jan-Feb       Impact factor: 3.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.